- Home
- WHD vs CRNX Comparison
WHD vs CRNX Comparison
Compare WHD & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHD
- CRNX
- Stock Information
- Founded
- WHD 2011
- CRNX 2008
- Country
- WHD United States
- CRNX United States
- Employees
- WHD N/A
- CRNX N/A
- Industry
- WHD Metal Fabrications
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- WHD Industrials
- CRNX Health Care
- Exchange
- WHD Nasdaq
- CRNX Nasdaq
- Market Cap
- WHD 3.0B
- CRNX 2.8B
- IPO Year
- WHD 2018
- CRNX 2018
- Fundamental
- Price
- WHD $45.81
- CRNX $31.75
- Analyst Decision
- WHD Hold
- CRNX Strong Buy
- Analyst Count
- WHD 6
- CRNX 8
- Target Price
- WHD $52.33
- CRNX $74.86
- AVG Volume (30 Days)
- WHD 593.6K
- CRNX 725.8K
- Earning Date
- WHD 07-30-2025
- CRNX 08-07-2025
- Dividend Yield
- WHD 1.13%
- CRNX N/A
- EPS Growth
- WHD 11.86
- CRNX N/A
- EPS
- WHD 2.83
- CRNX N/A
- Revenue
- WHD $1,136,010,000.00
- CRNX $760,000.00
- Revenue This Year
- WHD $1.08
- CRNX $402.02
- Revenue Next Year
- WHD $8.32
- CRNX $771.03
- P/E Ratio
- WHD $16.22
- CRNX N/A
- Revenue Growth
- WHD N/A
- CRNX N/A
- 52 Week Low
- WHD $33.80
- CRNX $24.10
- 52 Week High
- WHD $70.01
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- WHD 56.36
- CRNX 57.94
- Support Level
- WHD $45.18
- CRNX $28.98
- Resistance Level
- WHD $46.48
- CRNX $32.49
- Average True Range (ATR)
- WHD 1.46
- CRNX 1.24
- MACD
- WHD 0.03
- CRNX 0.30
- Stochastic Oscillator
- WHD 81.71
- CRNX 90.54
About WHD Cactus Inc.
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.